These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 20731252)
1. The use of placental S100 (S100P), GATA3 and napsin A in the differential diagnosis of primary adenocarcinoma of the bladder and bladder metastasis from adenocarcinoma of the lung. Raspollini MR; Comin CE; Crisci A; Chilosi M Pathologica; 2010 Feb; 102(1):33-5. PubMed ID: 20731252 [TBL] [Abstract][Full Text] [Related]
2. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray. Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449 [TBL] [Abstract][Full Text] [Related]
3. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion. Kim JH; Kim YS; Choi YD; Lee JS; Park CS Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739 [TBL] [Abstract][Full Text] [Related]
4. Expression of the urothelial differentiation markers GATA3 and placental S100 (S100P) in female genital tract transitional cell proliferations. Esheba GE; Longacre TA; Atkins KA; Higgins JP Am J Surg Pathol; 2009 Mar; 33(3):347-53. PubMed ID: 19092634 [TBL] [Abstract][Full Text] [Related]
5. Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung. Gruver AM; Amin MB; Luthringer DJ; Westfall D; Arora K; Farver CF; Osunkoya AO; McKenney JK; Hansel DE Arch Pathol Lab Med; 2012 Nov; 136(11):1339-46. PubMed ID: 23106579 [TBL] [Abstract][Full Text] [Related]
6. The utility of napsin-A in the identification of primary and metastatic lung adenocarcinoma among cytologically poorly differentiated carcinomas. Stoll LM; Johnson MW; Gabrielson E; Askin F; Clark DP; Li QK Cancer Cytopathol; 2010 Dec; 118(6):441-9. PubMed ID: 20830690 [TBL] [Abstract][Full Text] [Related]
7. Napsin A (TA02) is a useful alternative to thyroid transcription factor-1 (TTF-1) for the identification of pulmonary adenocarcinoma cells in pleural effusions. Dejmek A; Naucler P; Smedjeback A; Kato H; Maeda M; Yashima K; Maeda J; Hirano T Diagn Cytopathol; 2007 Aug; 35(8):493-7. PubMed ID: 17636482 [TBL] [Abstract][Full Text] [Related]
8. GATA3 expression in small cell carcinoma of bladder and prostate and its potential role in determining primary tumor origin. Bezerra SM; Lotan TL; Faraj SF; Karram S; Sharma R; Schoenberg M; Bivalacqua TJ; Netto GJ Hum Pathol; 2014 Aug; 45(8):1682-7. PubMed ID: 24925221 [TBL] [Abstract][Full Text] [Related]
9. Napsin A is useful to distinguish primary lung adenocarcinoma from adenocarcinomas of other organs. Suzuki A; Shijubo N; Yamada G; Ichimiya S; Satoh M; Abe S; Sato N Pathol Res Pract; 2005; 201(8-9):579-86. PubMed ID: 16259111 [TBL] [Abstract][Full Text] [Related]
10. Napsin A expression in primary mucin-producing adenocarcinomas of the lung: an immunohistochemical study. Wu J; Chu PG; Jiang Z; Lau SK Am J Clin Pathol; 2013 Feb; 139(2):160-6. PubMed ID: 23355200 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung. Whithaus K; Fukuoka J; Prihoda TJ; Jagirdar J Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas. Liu H; Shi J; Wilkerson ML; Lin F Am J Clin Pathol; 2012 Jul; 138(1):57-64. PubMed ID: 22706858 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma. Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550 [TBL] [Abstract][Full Text] [Related]
14. Plasmacytoid urothelial carcinoma of the urinary bladder: clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis of a case series. Raspollini MR; Sardi I; Giunti L; Di Lollo S; Baroni G; Stomaci N; Menghetti I; Franchi A Hum Pathol; 2011 Aug; 42(8):1149-58. PubMed ID: 21334719 [TBL] [Abstract][Full Text] [Related]
15. Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases. Martínez-Rodríguez M; Ramos D; Soriano P; Subramaniam M; Navarro S; Llombart-Bosch A Int J Surg Pathol; 2007 Apr; 15(2):213-8. PubMed ID: 17478786 [TBL] [Abstract][Full Text] [Related]
16. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung. Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700 [TBL] [Abstract][Full Text] [Related]
17. GATA3 expression in sarcomatoid urothelial carcinoma of the bladder. Fatima N; Osunkoya AO Hum Pathol; 2014 Aug; 45(8):1625-9. PubMed ID: 24824028 [TBL] [Abstract][Full Text] [Related]
18. Tissue-preserving antibody cocktails to differentiate primary squamous cell carcinoma, adenocarcinoma, and small cell carcinoma of lung. Brown AF; Sirohi D; Fukuoka J; Cagle PT; Policarpio-Nicolas M; Tacha D; Jagirdar J Arch Pathol Lab Med; 2013 Sep; 137(9):1274-81. PubMed ID: 23289761 [TBL] [Abstract][Full Text] [Related]
19. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337 [TBL] [Abstract][Full Text] [Related]
20. Thyroid transcription factor 1 and napsin a double staining in lung adenocarcinoma in pleural fluid. Liu L; Cohen C; Siddiqui MT Acta Cytol; 2012; 56(4):425-30. PubMed ID: 22846220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]